Frost Radar™: Soft Tissue Navigation Systems, 2023
Published on: 27-Jun-2023 | SKU: HC03681-GL-MR_27816

Need more details?
$4,950.00
DownloadLink
Need more details?

Robot-assisted surgery offers significant promise in driving down treatment costs and addressing the healthcare industry’s increasing burden of lifestyle-related diseases and demand for affordable care. Next-generation surgical robotics technology and surgical navigation systems complement and extend surgeons’ ability to minimize surgical variability, a key factor driving the adoption of surgical navigation systems platforms among hospitals, as now surgeons can perform complex tasks with greater control and less strain while ensuring patient safety.

With the advancement of digital and analytical technologies, deployment of artificial intelligence (AI) technologies, including machine learning and machine vision, in next-generation surgical platforms enables the systems to offer insights to surgeons based on analysis of the data collected. Moreover, haptic feedback signals when the pressure threshold is reached to prevent damaging anatomical structures. Flexible payment and leasing business models, improved ergonomics, multi-quadrant surgeries, reduced surgeon burnout, and occupation-related disease acquisition are key trends in this area. Frost & Sullivan expects the adoption of next-generation surgical navigation technology platforms to increase inpatient surgery volumes by reducing patients’ length of stay (LOS) and offer significant cost advantages for hospitals.

In a field of about 25 industry participants, this Frost Radar™ analysis highlights the top 11 companies that generated revenue from soft tissue surgical navigation systems between 2019 and 2022. These industry participants actively market, install, and develop surgical navigation platforms. Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™, considering their strengths and the opportunities that best fit those strengths.

Soft Tissue Navigation Systems 2023

  • Soft Tissue Navigation Systems

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform

Growth Index

Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.

  • Market Share (previous 3 years)
    This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years.
  • Revenue Growth (previous 3 years)
    This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™.
  • Growth Pipeline
    This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities.
  • Vision and Strategy
    This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision?
  • Sales and Marketing
    This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.

Innovation Index

Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.

  • INNOVATION SCALABILITY
    This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals.
  • RESEARCH AND DEVELOPMENT
    This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline.
  • PRODUCT PORTFOLIO
    This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue.
  • MEGATRENDS LEVERAGE
    This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline.
  • CUSTOMER ALIGNMENT
    This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.

Significance of Being on the Frost Radar™

Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.

  • GROWTH POTENTIAL
    Your organization has significant future growth potential, which makes it a Company to Action.
  • BEST PRACTICES
    Your organization is well positioned to shape Growth Pipeline™ best practices in your industry.
  • COMPETITIVE INTENSITY
    Your organization is one of the key drivers of competitive intensity in the growth environment.
  • CUSTOMER VALUE
    Your organization has demonstrated the ability to significantly enhance its customer value proposition.
  • PARTNER POTENTIAL
    Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Robot-assisted surgery offers significant promise in driving down treatment costs and addressing the healthcare industry’s increasing burden of lifestyle-related diseases and demand for affordable care. Next-generation surgical robotics technology and surgical navigation systems complement and extend surgeons’ ability to minimize surgical variability, a key factor driving the adoption of surgical navigation systems platforms among hospitals, as now surgeons can perform complex tasks with greater control and less strain while ensuring patient safety. With the advancement of digital and analytical technologies, deployment of artificial intelligence (AI) technologies, including machine learning and machine vision, in next-generation surgical platforms enables the systems to offer insights to surgeons based on analysis of the data collected. Moreover, haptic feedback signals when the pressure threshold is reached to prevent damaging anatomical structures. Flexible payment and leasing business models, improved ergonomics, multi-quadrant surgeries, reduced surgeon burnout, and occupation-related disease acquisition are key trends in this area. Frost & Sullivan expects the adoption of next-generation surgical navigation technology platforms to increase inpatient surgery volumes by reducing patients’ length of stay (LOS) and offer significant cost advantages for hospitals. In a field of about 25 industry participants, this Frost Radar™ analysis highlights the top 11 companies that generated revenue from soft tissue surgical navigation systems between 2019 and 2022. These industry participants actively market, install, and develop surgical navigation platforms. Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™, considering their strengths and the opportunities that best fit those strengths.
More Information
Deliverable Type Frost Radar
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Surgical Navigation Systems
Keyword 2 Soft Tissue Navigation
Keyword 3 Soft tissue monitoring
Podcast No
WIP Number K907-01-00-00-00

Frost Radar™: Soft Tissue Navigation Systems, 2023

HealthcareFrost Radar™: Soft Tissue Navigation Systems, 2023

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

RELEASE DATE
27-Jun-2023
REGION
Global
Deliverable Type
Frost Radar
Research Code: K907-01-00-00-00
SKU: HC03681-GL-MR_27816
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC03681-GL-MR_27816